Images List Premium Download Classic

Weight Loss

Weight Loss-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Core 22 human training and weight loss system
July 13, 2017 - N°20170200392

The system of the preferred embodiments is a method for human training coordinated by a computer interface, where a human user interacts with at least one computing interface; where the at least one computing is provided by a computing device having at least one processor, computer readable storage medium, and a network connection to at least one additional computing device; ...
Oxyntomodulin analogs and methods of making and using same
California Institute For Biomedical Research
July 13, 2017 - N°20170196940

Provided are oxyntomodulin analogs. The peptide analogs have at least two cysteines. The two cysteines are separated by six amino acids such that they can be crosslinked using suitable crosslinking moieties. The crosslinked peptides have long half-lives and/or efficacy. For example, peptide analog compositions are used for inducing weight loss and/or reducing blood glucose levels.
Implantable weight control device to promote early and prolonged satiety in a bariatric patient
Agt Inc.
July 13, 2017 - N°20170196719

The present disclosure provides an inflatable weight control device that is implanted long-term with an endoscope in obese and bariatric human patients to promote early and prolonged satiety. The device includes a flexible member coupled to a valve body assembly and an elongated durable module residing within the flexible member. The flexible member is selectively inflated to form two bulbs ...
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery ...
Dow Global Technologies Llc
June 29, 2017 - N°20170182299

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, attention deficit disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood ...
Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat ...
University Of Copenhagen
June 22, 2017 - N°20170173099

The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, overweight and ...
Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
Nestec S.a.
June 15, 2017 - N°20170164648

Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde and zinc but ...
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Small molecule compound and synthesizing method and uses thereof
Technoderma Medicines Pte Ltd.
June 08, 2017 - N°20170158651

Provided is a small molecule compound as represented by structural formula (i). The product of the present invention in various concentrations and dosages can achieve an obvious change in the growth period of hairs, promoting the growth of the hairs, thus exhibiting an obvious effect of promoting hair growth. In addition, changes in the weight of a mouse in each ...
Plant extract composition for reducing topical fat and promoting weight loss as well as applications ...
Caliway Biopharmaceuticals Co., Ltd.
June 08, 2017 - N°20170157195

Disclosed in the present invention is the composition for reducing local fat and body weight, and pharmaceuticals and use thereof. The composition contains resveratrol and curcumin extract at a weight ration from 1:30 to 10:1. The composition and pharmaceuticals thereof of the invention can inhibit the growth of fat cells, cause planned apoptosis of fat cells, achieve the effects of reducing fat ...
Composition of plant extract and its pharmaceutical composition and application thereof
Caliway Biopharmaceuticals Co., Ltd.
June 08, 2017 - N°20170157194

Provided is a plant extract composition and a pharmaceutical composition thereof for reducing body weight and body fat, wherein the plant extract composition comprises a green tea extract and a turmeric extract respectively 30 wt % to 75 wt % and 20 wt % to 55 wt % of a total weight of the composition. In diet-induced obesity models, either obesity is induced first or simultaneously with administration, ...
Plant extract composition for reducing topical fat and promoting weight loss as well as application ...
Caliway Biopharmaceuticals Co., Ltd.
June 08, 2017 - N°20170157193

Provided is a composition and a pharmaceutical composition for reducing topical fat or promoting weight loss, wherein the composition comprises a plant extract composition comprising resveratrol and turmeric extract and a weight ratio of resveratrol and turmeric extract ranges from 1:30 to 10:1. The composition and the pharmaceutical composition are primarily administered through topical injection to inhibit the growth of fat cells ...
Anti-depression compounds
Board Of Regents Of The University Of Texas System
June 08, 2017 - N°20170157092

This technology relates generally to compounds and methods for stimulating neurogenesis (e. G., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death. Various compounds are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal ...
Methods and devices for activating brown adipose tissue with targeted substance delivery
The General Hospital Corporation D/b/a, Massachusetts General Hospital
June 08, 2017 - N°20170156907

Methods and devices are provided for activating brown adipose tissue with targeted substance delivery. Generally, the methods and devices can activate bat to increase thermogenesis, e. G., increase heat production in the patient, which over time can lead to weight loss and/or improved metabolic function. In one embodiment, a chemical configured to stimulate nerves that activate the bat and/...
Methods for determining gene-nutrient interactions
Bodysync, Inc.
June 01, 2017 - N°20170152559

The present invention provides methods and tests that allow for the establishment of personalized weight-management programs for an individual based upon the individual's genotype in the glutathione s-transferase pi gene and/or the interleukin-6 gene. Methods are disclosed for determining the individual's genotype, which may be used to select an appropriate therapeutic/dietary program or lifestyle recommendation. Such a personalized ...
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
F10 inhibits growth of pc3 xenografts and enhances the effects of radiation therapy
Wake Forest University
June 01, 2017 - N°20170151240

Chemotherapy remains of limited use for the treatment of prostate cancer with only one drug, docetaxel, demonstrating a modest survival advantage for treatment of late-stage disease. Data from the nci 60 cell line screen indicated that the castration-resistant prostate cancer cell lines pc3 and du145 were more sensitive than average to the novel polymeric fluoropyrimidine (fp), f10, despite displaying less than ...
Low dose topiramate/phentermine composition and methods of use thereof
Vivus, Inc.
June 01, 2017 - N°20170151179

A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form, in a daily dose in the range of 2 mg to 8 mg, in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. Methods for treating obesity, conditions associated ...
Peptide yy (pyy) analogues
Imperial Innovations Limited
May 18, 2017 - N°20170137486

Analogues of peptide yy (pyy), which are useful in treating disorders such as diabetes and obesity and also for inducing cosmetic weight loss, related compositions, formulations, uses and methods.
Method and system for increasing brown adipose tissue activity during sleep
Imperial Innovations Limited
May 18, 2017 - N°20170136203

A method and system is provided for increasing brown adipose tissue deposits and activity by breathing air from a cpap machine having a chiller which cools the air to less than 55° f. Before discharge from the cpap mask to the person's lungs while sleeping. The cool air increases brown adipose tissue development and activity, thereby increasing caloric expenditures, so ...
Exercise sauna having far infrared heating elements and configurable seating
Imperial Innovations Limited
May 11, 2017 - N°20170131693

A far infrared (“fir”) sauna cabin equipped with a far infrared (“fir”) heating elements constructed of ceramic, carbon, and/or light emitting diodes (“led”), designed for therapeutic use in a sauna, capable of emitting far infrared energy, and heating an individual's skin for purposes of rejuvenation, anti-aging, weight ...
Hmg1 antibody for treating inflammatory conditions
The Feinstein Institute For Medical Research
May 11, 2017 - N°20170129946

There is disclosed a pharmaceutical composition and method for treating sepsis, including septic shock and ards (acute respiratory distress syndrome), comprising administering an effective amount of a hmg1 antagonist. There is further disclosed a diagnostic method for monitoring the severity or potential lethality of sepsis or septic shock, comprising measuring the serum concentration of hmg1 in a patient exhibiting or ...
Method for modifying nickel microparticles and method for producing nickel microparticles
The Feinstein Institute For Medical Research
May 11, 2017 - N°20170129008

Provided is a method for modifying nickel microparticles comprising a step of making an acid and/or hydrogen peroxide act on nickel microparticles weight loss of which occurs due to heat treatment such as burning and a method for producing nickel microparticles comprising the modification method. The step of making an acid and/or hydrogen peroxide act reduces a rate ...
Use of ave0010 for the treatment of diabetes mellitus type 2
Sanofi-aventis Deutschland Gmbh
May 04, 2017 - N°20170119852

The present invention refers to the use of lixisenatide or/and a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of diabetes mellitus type 2, for inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients.
Loading